Understanding this biological reality helps set realistic expectations during the recovery window
This is not fixing the underlying problem, per se, because our bodies just strive for these higher weights
This is similar to whats reported in FDA data, which shows the most common side effect, nausea, happens in 44% of people on Wegovy (compared to 16% of people on a placebo)
What Medical Studies Reveal About Tirzepatide and Zepbound Trusted sources highlight the need to understand the difference between branding and the actual medication
Not always, but its recommended
Priority Applications (2) Applications Claiming Priority (2) Publications (1) Family ID=84370815 Family Applications (1) Country Status (3) Cited By (10) Citations (7) 2022 2022-11-22 WO PCT/IB2022/061286 patent/WO2023089594A1/en not_active Ceased 2022-11-22 US US18/712,627 patent/US20250019410A1/en active Pending 2022-11-22 EP EP22817378.7A patent/EP4436991A1/en not_active Withdrawn